Non-Billable / Non-Specific Code
ICD-10-CM D3A is the diagnosis code for Benign neuroendocrine tumors. This code falls under the section "Benign neuroendocrine tumors" within Chapter 2 â Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions are not included in D3A. If the patient has both, code each condition separately:
Understanding where D3A sits in the ICD-10-CM classification helps ensure proper coding:
No, D3A is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D3A is the ICD-10-CM diagnosis code for "Benign neuroendocrine tumors". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
D3A is located in Section D3A â "Benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
D3A has 2 sub-code(s) that provide more specific detail: D3A.0, D3A.8.
Use D3A when the patients documented diagnosis matches "Benign neuroendocrine tumors" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Benign neuroendocrine tumors is D3A.
No, D3A is non-billable. Use a more specific sub-code for primary diagnosis billing.
D3A is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D3A is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.